STATE STREET CORP Initiates New Position in CVS Health Corporation (CVS)
STATE STREET CORP, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q2 2026, according to its most recent 13F filing with the…
01State Street Corp purchased 60.3 million CVS shares valued at $6.2 billion in Q2 2026, establishing a significant new institutional position.
02CVS Health trades at $86.35 per share with a $102.6 billion market capitalization as of the filing date.
0313F filings reflect portfolio holdings as of quarter-end and are filed up to 45 days later, so positions may have changed since disclosure.
04Large institutional positions can influence trading dynamics and are monitored by investors tracking institutional money flows.
05Healthcare sector positions are often driven by regulatory developments, pipeline progress, and long-term demand from an aging population.
Filing Details
STATE STREET CORP, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q2 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 60,283,408 shares of the Healthcare company, valued at approximately $6.2B as of the filing date.
Market Context
CVS Health Corporation's stock currently trades at $86.35 with a market capitalization of $102.6B.
A new institutional position can signal growing confidence in a company's prospects. When large asset managers like STATE STREET CORP establish stakes, it often reflects months of due diligence and a conviction that the stock is undervalued or poised for growth. Retail investors often track 13F filings to identify stocks that institutional money is moving into.
Healthcare stocks have attracted institutional attention as an aging population drives long-term demand. CVS Health Corporation operates in a sector where regulatory developments and pipeline progress can significantly impact institutional positioning.
The size of this position — $6.24 billion — places it among the more significant institutional holdings in CVS Health Corporation. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like STATE STREET CORP position their portfolios.